Hong Kong Stocks Movement | CLOVER BIO-B (02197) Falls Over 9% After Earnings Release, Interim Adjusted Loss of RMB 97.638 Million, Up 11.89% Year-over-Year

Stock News08-28

CLOVER BIO-B (02197) dropped over 9% following its earnings announcement. As of the time of writing, the stock fell 9.21% to HK$0.69, with a trading volume of HK$4.9971 million.

On the news front, CLOVER BIO-B released its interim results for the six months ended June 30, 2025, on August 27. The group recorded revenue of RMB 3.254 million, other income and gains of RMB 17.646 million, down 73.72% year-over-year, and an adjusted loss for the period of RMB 97.638 million, up 11.89% year-over-year. The loss attributable to owners of the parent company was RMB 101 million, up 6.46% year-over-year, with a loss per share of RMB 0.08.

The announcement stated that despite continued improvement in operational efficiency, the loss for the period increased by RMB 6.2 million from RMB 95.1 million for the six months ended June 30, 2024, to RMB 101 million for the six months ended June 30, 2025. This increase was mainly due to one-time and non-recurring other income recognized in 2024 from partial forgiveness of trade payables.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1143448670?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-28 11:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143448670","market":"fut","top_or_hot":-1,"title":"Hong Kong Stocks Movement | CLOVER BIO-B (02197) Falls Over 9% After Earnings Release, Interim Adjusted Loss of RMB 97.638 Million, Up 11.89% Year-over-Year","media":"Stock News","content":"<p>CLOVER BIO-B (02197) dropped over 9% following its earnings announcement. As of the time of writing, the stock fell 9.21% to HK$0.69, with a trading volume of HK$4.9971 million.</p>\n<p>On the news front, CLOVER BIO-B released its interim results for the six months ended June 30, 2025, on August 27. The group recorded revenue of RMB 3.254 million, other income and gains of RMB 17.646 million, down 73.72% year-over-year, and an adjusted loss for the period of RMB 97.638 million, up 11.89% year-over-year. The loss attributable to owners of the parent company was RMB 101 million, up 6.46% year-over-year, with a loss per share of RMB 0.08.</p>\n<p>The announcement stated that despite continued improvement in operational efficiency, the loss for the period increased by RMB 6.2 million from RMB 95.1 million for the six months ended June 30, 2024, to RMB 101 million for the six months ended June 30, 2025. This increase was mainly due to one-time and non-recurring other income recognized in 2024 from partial forgiveness of trade payables.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Stocks Movement | CLOVER BIO-B (02197) Falls Over 9% After Earnings Release, Interim Adjusted Loss of RMB 97.638 Million, Up 11.89% Year-over-Year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Stocks Movement | CLOVER BIO-B (02197) Falls Over 9% After Earnings Release, Interim Adjusted Loss of RMB 97.638 Million, Up 11.89% Year-over-Year\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-08-28 11:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CLOVER BIO-B (02197) dropped over 9% following its earnings announcement. As of the time of writing, the stock fell 9.21% to HK$0.69, with a trading volume of HK$4.9971 million.</p>\n<p>On the news front, CLOVER BIO-B released its interim results for the six months ended June 30, 2025, on August 27. The group recorded revenue of RMB 3.254 million, other income and gains of RMB 17.646 million, down 73.72% year-over-year, and an adjusted loss for the period of RMB 97.638 million, up 11.89% year-over-year. The loss attributable to owners of the parent company was RMB 101 million, up 6.46% year-over-year, with a loss per share of RMB 0.08.</p>\n<p>The announcement stated that despite continued improvement in operational efficiency, the loss for the period increased by RMB 6.2 million from RMB 95.1 million for the six months ended June 30, 2024, to RMB 101 million for the six months ended June 30, 2025. This increase was mainly due to one-time and non-recurring other income recognized in 2024 from partial forgiveness of trade payables.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02197","symbol_name":"三叶草生物-B","start_time":0,"source_url":"","article_id":"1143448670","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143448670","pubTimestamp":1756351580,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"CLOVER BIO-B (02197) dropped over 9% following its earnings announcement. As of the time of writing, the stock fell 9.21% to HK$0.69, with a trading volume of HK$4.9971 million. On the news front,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02197":"三叶草生物-B","BK1161":"生物科技"},"translate_title":"港股动向|三叶草生物-B(02197)财报发布后跌超9%中期经调整亏损人民币9763.8万元同比增11.89%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02197":1},"content_text":"CLOVER BIO-B (02197) dropped over 9% following its earnings announcement. As of the time of writing, the stock fell 9.21% to HK$0.69, with a trading volume of HK$4.9971 million.\nOn the news front, CLOVER BIO-B released its interim results for the six months ended June 30, 2025, on August 27. The group recorded revenue of RMB 3.254 million, other income and gains of RMB 17.646 million, down 73.72% year-over-year, and an adjusted loss for the period of RMB 97.638 million, up 11.89% year-over-year. The loss attributable to owners of the parent company was RMB 101 million, up 6.46% year-over-year, with a loss per share of RMB 0.08.\nThe announcement stated that despite continued improvement in operational efficiency, the loss for the period increased by RMB 6.2 million from RMB 95.1 million for the six months ended June 30, 2024, to RMB 101 million for the six months ended June 30, 2025. This increase was mainly due to one-time and non-recurring other income recognized in 2024 from partial forgiveness of trade payables.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1143448670","isCrawlerRequest":true}